Carimmune NF is the preferred IVIG formlation at TBH. It provides enhanced patient protection against a broader range of pathogens (i.e. enveloped viruses, parasites, etc.) Subtle differences exist between IVIG products with respect to osmolarity. IgA and sucrose content. Although the risk for developing renal insufficiency is low with IVIG, the following product selection criteria are recommended:
Insuring adequate hydration (example: 1/2NS or D51/2NS at 1 ml/kg/hr 6 hrs. NS bolus) pre-, peri-, and post infusion should also be considered.